STOCK TITAN
  1. Home
  2. NPTX

Neuropathix (NPTX) Stock Price, News & Analysis

NPTX OTC

Company Description

Neuropathix (OTC: NPTX) is classified in the software and other prerecorded compact disc, tape, and record reproducing industry within the Manufacturing sector.

This page collects what Stock Titan holds for NPTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
93.8M
Shares outstanding

Latest News

View All
+8.33%

Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS

+19.94%

Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

clinical trial
+0.25%

Neuropathix, Inc. CEO Issues New Letter to Shareholders; Updates Market on Milestones in Research and Funding

+5.49%

Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company’s Scientific Advisory Board

management
+2.60%

Neuropathix, Inc. Receives Patent Grant from India for Its Novel Anti-Inflammatory Compounds

+38.94%

Neuropathix, Inc. Chooses Purisys for Process Optimization and Scale Up of Its Lead Drug Candidate KLS-13019

Neuropathix has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, management. View all NPTX news →

SEC Filings

View All

No SEC filings available for NPTX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

NPTX Company Profile & Sector Positioning

Neuropathix (NPTX) operates in the Software and Other Prerecorded Compact Disc, Tape, and Record Reproducing industry within the broader Manufacturing sector and is listed on the OTC.